SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056960
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:09
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eq-20240331.htm   iXBRL 10-Q 1838881
2 EX-10.1 eq-ex10_1.htm EX-10.1 435053
3 EX-31.1 eq-ex31_1.htm EX-31.1 11575
4 EX-31.2 eq-ex31_2.htm EX-31.2 11723
5 EX-32.1 eq-ex32_1.htm EX-32.1 9753
  Complete submission text file 0000950170-24-056960.txt   7877073

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eq-20240331.xsd EX-101.SCH 1166068
65 EXTRACTED XBRL INSTANCE DOCUMENT eq-20240331_htm.xml XML 1053274
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 24930696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)